Yuzo Shimazu

406 total citations
21 papers, 218 citations indexed

About

Yuzo Shimazu is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yuzo Shimazu has authored 21 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 4 papers in Epidemiology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yuzo Shimazu's work include SARS-CoV-2 and COVID-19 Research (9 papers), SARS-CoV-2 detection and testing (5 papers) and COVID-19 Clinical Research Studies (4 papers). Yuzo Shimazu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), SARS-CoV-2 detection and testing (5 papers) and COVID-19 Clinical Research Studies (4 papers). Yuzo Shimazu collaborates with scholars based in Japan, United Kingdom and Thailand. Yuzo Shimazu's co-authors include Masaharu Tsubokura, Yurie Kobashi, Yoshitaka Nishikawa, Takeshi Kawamura, Tatsuhiko Kodama, Tianchen Zhao, Yudai Kaneko, Makoto Yoshida, Chika Yamamoto and Naomi Ito and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Yuzo Shimazu

19 papers receiving 213 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuzo Shimazu Japan	9	133	89	47	28	25	21	218
K. Danielle Lecy United States	3	203 1.5×	83 0.9×	68 1.4×	38 1.4×	11 0.4×	4	283
Tomer Meir Israel	3	125 0.9×	73 0.8×	87 1.9×	20 0.7×	15 0.6×	4	218
Chunhuan Zhang China	9	228 1.7×	140 1.6×	73 1.6×	29 1.0×	12 0.5×	13	322
Mario Martín-Sánchez Spain	11	129 1.0×	37 0.4×	34 0.7×	67 2.4×	28 1.1×	18	236
Usha Samala United States	7	108 0.8×	35 0.4×	32 0.7×	13 0.5×	18 0.7×	7	178
Katelynn Devinney United States	5	78 0.6×	25 0.3×	51 1.1×	33 1.2×	15 0.6×	9	213
Christina Hu United Kingdom	3	190 1.4×	100 1.1×	48 1.0×	18 0.6×	8 0.3×	6	226
Wiebe Külper‐Schiek Germany	6	182 1.4×	113 1.3×	54 1.1×	33 1.2×	7 0.3×	8	234
A. S. M. Roknuzzaman Bangladesh	9	92 0.7×	36 0.4×	33 0.7×	25 0.9×	15 0.6×	24	207
Keya Joshi United States	6	124 0.9×	34 0.4×	80 1.7×	44 1.6×	9 0.4×	20	185

Countries citing papers authored by Yuzo Shimazu

Since Specialization

Citations

This map shows the geographic impact of Yuzo Shimazu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuzo Shimazu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuzo Shimazu more than expected).

Fields of papers citing papers by Yuzo Shimazu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuzo Shimazu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuzo Shimazu. The network helps show where Yuzo Shimazu may publish in the future.

Co-authorship network of co-authors of Yuzo Shimazu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuzo Shimazu. A scholar is included among the top collaborators of Yuzo Shimazu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuzo Shimazu. Yuzo Shimazu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kobashi, Yurie, Takeshi Kawamura, Yuzo Shimazu, et al.. (2024). Kinetics of humoral and cellular immune responses 5 months post-COVID-19 booster dose by immune response groups at the peak immunity phase: An observational historical cohort study using the Fukushima vaccination community survey. Vaccine X. 20. 100553–100553. 1 indexed citations

Takita, Morihito, Yurie Kobashi, Masatoshi Wakui, et al.. (2023). Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, Japan. Vaccines. 11(5). 920–920. 5 indexed citations

Yoshida, Makoto, Yurie Kobashi, Takeshi Kawamura, et al.. (2023). Association of systemic adverse reaction patterns with long-term dynamics of humoral and cellular immunity after coronavirus disease 2019 third vaccination. Scientific Reports. 13(1). 7 indexed citations

Kobashi, Yurie, Yuzo Shimazu, Takeshi Kawamura, et al.. (2022). Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine. PLoS ONE. 17(6). e0269917–e0269917. 17 indexed citations

Kobashi, Yurie, Yoshitake Takebayashi, Makoto Yoshida, et al.. (2022). Waning of Humoral Immunity and the Influencing Factors after BNT162b2 Vaccination: A Cohort Study with a Latent Growth Curve Model in Fukushima. Vaccines. 10(12). 2007–2007. 4 indexed citations

Yoshida, Makoto, Yurie Kobashi, Takeshi Kawamura, et al.. (2022). Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey. Vaccines. 10(4). 515–515. 57 indexed citations

Yoshida, Makoto, Yurie Kobashi, Yuzo Shimazu, et al.. (2022). Time course of adverse reactions following BNT162b2 vaccination in healthy and allergic disease individuals aged 5–11 years and comparison with individuals aged 12–15 years: an observational and historical cohort study. European Journal of Pediatrics. 182(1). 123–133. 7 indexed citations

Kobashi, Yurie, et al.. (2022). Maturing of public-private-people partnership (4P): Lessons from 4P for triple disaster and subsequently COVID-19 pandemic in Fukushima. Journal of Global Health. 12. 3028–3028. 10 indexed citations

Shimazu, Yuzo, Yurie Kobashi, Seiya Imoto, & Masaharu Tsubokura. (2022). A retrospective observational study analyzing work and study motivation based on the work environment of 15,677 Japanese clinicians in 2016. Scientific Reports. 12(1). 14806–14806. 1 indexed citations

10.

Kobashi, Yurie, et al.. (2022). Japanese anesthesiologists’ knowledge of the cost of medicines and their attitudes toward cost containment: a cross-sectional survey. Journal of Rural Medicine. 17(3). 131–136.

11.

Kobashi, Yurie, Yuzo Shimazu, Takeshi Kawamura, et al.. (2022). Peak IgG antibody titers against SARS-CoV-2 spike protein following immunization with the Pfizer/BioNTech BNT162b2 vaccine. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE. 68(1). 67–70. 8 indexed citations

12.

Murakami, Michio, Fuminari Miura, Masaaki Kitajima, et al.. (2021). COVID-19 risk assessment at the opening ceremony of the Tokyo 2020 Olympic Games. Microbial Risk Analysis. 19. 100162–100162. 21 indexed citations

13.

Kobashi, Yurie, Yoshitaka Nishikawa, Takeshi Kawamura, et al.. (2021). Seroprevalence of SARS-CoV-2 antibodies among hospital staff in rural Central Fukushima, Japan: A historical cohort study. International Immunopharmacology. 98. 107884–107884. 11 indexed citations

14.

Shimazu, Yuzo, Yurie Kobashi, Tianchen Zhao, et al.. (2021). Mental distress in a clinical nurse due to a false‐positive COVID‐19 antibody test result during the COVID‐19 epidemic in Japan: A case report. SHILAP Revista de lepidopterología. 9(5). e04122–e04122. 6 indexed citations

15.

Yoshida, Makoto, Toyoaki Sawano, Akihiko Ozaki, et al.. (2021). Importance of individualized disaster preparedness for hospitalized or institutionalized patients: Lessons learned from the legal revisions made to the Basic Act on Disaster Management in Japan following the Fukushima nuclear disaster. Journal of Global Health. 11. 3108–3108. 4 indexed citations

16.

Tsubokura, Masaharu, et al.. (2021). The Nepalese health care system and challenges during COVID-19. Journal of Global Health. 11. 3030–3030. 15 indexed citations

17.

Shimazu, Yuzo, Masao Murakami, Ichiro Seto, et al.. (2020). Age as a decisive factor in general anaesthesia use in paediatric proton beam therapy. Scientific Reports. 10(1). 15096–15096. 20 indexed citations

18.

Kobashi, Yurie, Yuzo Shimazu, Yoshitaka Nishikawa, et al.. (2020). The difference between IgM and IgG antibody prevalence in different serological assays for COVID-19; lessons from the examination of healthcare workers. International Immunopharmacology. 92. 107360–107360. 19 indexed citations

19.

Shimazu, Yuzo, et al.. (2016). [A Case of Anaphylaxis during Anesthesia Caused Twice by Rocuronium Bromide.]. PubMed. 65(8). 817–819.

20.

Shimazu, Yuzo, et al.. (1966). Research on dengue in tissue culture. II. Further observations on virus-tissue culture affinity.. PubMed. 12(4). 189–98. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact